Skip to content

Stanford Medicine magazine explores the molecules behind human biology and how understanding them fuels medical discoveries and innovations.

Stanford Medicine magazine explores the molecules behind human biology and how understanding them fuels medical discoveries and innovations.

Research from early clinical trials of pediatric glioma patients shows that altered immune cells can fight the deadly brainstem tumor.

Research from early clinical trials of pediatric glioma patients shows that altered immune cells can fight the deadly brainstem tumor.

Published on

Stanford Medicine Scientists have devised a blood test to predict some cancer relapses after patients have already been treated.

Stanford Medicine Scientists have devised a blood test to predict some cancer relapses after patients have already been treated.

Published on

A new way to deliver mRNA as a COVID-19 vaccine may avoid side effects and increase customization to prevent infection.

A new way to deliver mRNA as a COVID-19 vaccine may avoid side effects and increase customization to prevent infection.

'Resting' exhausted cancer-fighting immune cells enhances their tumor-killing activity, which may help people with blood and solid cancers.

'Resting' exhausted cancer-fighting immune cells enhances their tumor-killing activity, which may help people with blood and solid cancers.

A Stanford-developed anti-cancer therapy currently in clinical trials may also reduce vascular inflammation in heart disease.

A Stanford-developed anti-cancer therapy currently in clinical trials may also reduce vascular inflammation in heart disease.

Published on

Pioneering immunotherapy drug Provenge is enjoying a revival, thanks to a large new clinical trial that will test it in men with early prostate cancer.

Pioneering immunotherapy drug Provenge is enjoying a revival, thanks to a large new clinical trial that will test it in men with early prostate cancer.

Scientists have made an important step forward in treating a deadly childhood brain tumor, using T cells engineered to target a surface sugar found on the cancer cells.

Scientists have made an important step forward in treating a deadly childhood brain tumor, using T cells engineered to target a surface sugar found on the cancer cells.